Rights and permissions
About this article
Cite this article
Infliximab beneficial in refractory systemic vasculitides. Inpharma Wkly. 1369, 17 (2003). https://doi.org/10.2165/00128413-200313690-00028
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200313690-00028